Radioactive drug seeks and attacks advanced breast cancer in first human test
NCT ID NCT07081555
Summary
This is the first time a new radioactive drug called [177Lu]Lu-ABY-271 is being tested in people. The study aims to see if it is safe and how it moves to tumors and organs in patients with advanced HER2-positive breast cancer that has spread. It will involve up to 21 participants who have already tried several other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Akademiska Sjukhuset
RECRUITINGUppsala, SE-751 85, Sweden
-
Karolinska University Hospital
RECRUITINGStockholm, SE-17164, Sweden
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, S-413 45, Sweden
Conditions
Explore the condition pages connected to this study.